Fundz

Shuttle Pharmaceuticals Holdings reported raising $9.96 Million in an initial SEC Form D filing, from an offering of $9.96 Million

PUBLIC · SHPHMay 15, 2026

Amount Raised

$9.96 Million

$9.96 Million sold, per SEC Form D (first sale Apr 30, 2026)

Round Type

Venture

GaithersburgBiotechnologyHealth CareMedicalPharmaceutical

Who else raised in Medical and Pharmaceutical around the same time

Companies in the same sectors as Shuttle Pharmaceuticals Holdings that raised within 45 days of this round, from Fundz verified event records.

  • Ingenix raised $15M (Seed) on June 3, 2026.
  • Citius Oncology raised $37M on May 6, 2026.
  • ThruFlo Endovascular raised an undisclosed amount (Seed) on June 11, 2026.
  • NVENTRIC raised $23M on June 10, 2026.
  • Uncovr raised $7M (Seed) on June 10, 2026.
  • FesariusTherapeutics raised $20M (Series A) on June 10, 2026.

Who to call at Shuttle Pharmaceuticals Holdings, and when

A new round usually means Shuttle Pharmaceuticals Holdings is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Shuttle Pharmaceuticals Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Shuttle Pharmaceuticals Holdings, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Shuttle Pharmaceuticals Holdings. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Shuttle Pharmaceuticals Holdings

Location

Gaithersburg, Maryland, United States

About

Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT). Founded in 2012 by faculty members of the Georgetown University Medical Center, Shuttle Pharma's mission is to improve the lives of cancer patients by developing therapies that are designed to maximize the effectiveness of RT while limiting the side effects of radiation in cancer treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Shuttle Pharmaceuticals Holdings raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Shuttle Pharmaceuticals Holdings's next move

See what Strategic adds

Shuttle Pharmaceuticals Holdings raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.